Abstract
Renal Cell Cancer is diagnosed in about 30,000 patients/year and accounts for 3% of the malignancies in adults in the United States. Advanced Renal Cell Cancer carries a poor prognosis. New treatment strategies such as immuno-therapy are being employed in an attempt to delay the progression of disease but remain controversial. Non-invasive tests for diagnosing, staging and monitoring the course of disease would be desirable. The current procedures for staging and re-staging of patients with renal cell cancer consist primarily of anatomic imaging modalities.
A small number of studies have addressed the potential role of FDG-PET for staging of renal cell cancer.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Suggested Reading
Renal Cell Cancer
Kocher F, Grimmel S, Hautmann R, Reske SN. Positron emission tomography. Introduction of a new procedure in diagnosis of urologic tumors and initial clinical results. J Nucl Med. 1994;35:223P.
Bachor R, Kotzerke J, Gottfried HW, Brandie E, Reske SN, Hautmann R. Positron emission tomography in diagnosis of renal cell carcinoma. Urologe A. 1996;35(2): 146–150.
Miyauchi T, Brown RS, Grossman HB, Wojno K, Wahl RL. Correlation between visualization of primary renal cancer by FDG-PET and histopathological findings. J Nucl Med. 1996;37(5 Suppl):64P.
Goldberg MA, Mayo-Smith WW, Papanicolaou N, Fischman AJ, Lee MJ. FDG PET characterization of renal masses: preliminary experience. Clin Radiol. 1997;52(7):510–515.
Montravers F, Grahek D, Kerrou K, Younsi N, Doublet JD, Gattegno B, Rossert J, Costa de Beauregard MA, Thibault P, Talbot JN. Evaluation of FDG uptake by renal malignancies (primary tumor or metastases) using a coincidence detection gamma camera. J Nucl Med. 2000;41(1):78–84.
Safaei A, Figlin R, Hoh CK, Silverman DH, Seltzer M, Phelps ME, Czernin J. The usefulness of F-18 deoxyglucose wholebody positron emission tomography (PET) for re-staging of renal cell cancer. Clin Nephrol. 2002;57(1):56–62.
Testicular Cancer
Cremerius U, Effert PJ, Adam G, Sabri O, Zimny M, Wagenknecht G, Jakse G, Buell U. FDG PET for detection and therapy control of metastatic germ cell tumor. J Nucl Med. 1998;39(5):815–822.
Cremerius U, Wildberger H, Borchers H, Zimny M, Jakse G, Gunther RW, Buell U. Does positron emission tomography using 18-fluoro-2-deoxyglucose improve clinical staging of testicular caner?—Results of a study in 50 patients. Urology. 1999;54(5):900–904.
Prostrate Cancer
Effert PJ, Bares R, Handt S, Wolff JM, Büll U, Jakse G. Metabolic imaging of untreated prostate cancer by positron emission tomography with 18fluorine-labeled deoxyglucose. J Urol. 1996;155(3):994–998.
Shreve PD, Grossman HB, Gross MD, Wahl RL. Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18] fluoro-D-glucose. Radiology. 1996;199(3):751–756.
Yeh SD, Imbiraco M, Larson SM, Garza D, Zhang JJ, Kalaigian H, Finn RD, Reddy D, Horowitz SM, Goldsmith SJ, Scher HI. Detection of bony metastases of androgen-independent prostate cancer by PET-FDG. Nucl Med Biol. 1996;23(6):693–697.
Seltzer MA, Barbaric Z, Belldegrun A, Naitoh J, Dorey F, Phelps ME, Gambhir SS, Hoh CK. Comparison of helical computerized tomography, positron emission tomography and monoclonal antibody scans for evaluating lymph node metastases in patients with prostate specific antigen relapse after treatment for localized prostate cancer. J Urol. 1999;162(4):1322–1328.
Liu IJ, Zafar MB, Lai YH, Segall GM, Terris MK. Fluorodeoxyglucose positron emission tomography studies in diagnosis and staging of clinically organ-confined prostate cancer. Urology. 2001;57(1):108–111.
Bladder Cancer
Kosuda S, Kison PV, Greenough R, Grossman HDB, Wahl RL. Preliminary assessment of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with bladder cancer. Eur J Nucl Med. 1997:24(6):615–620.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Czernin, J., Dahlbom, M., Ratib, O., Schiepers, C. (2004). Cancers of the Genito-Urinary System. In: Atlas of PET/CT Imaging in Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18517-5_19
Download citation
DOI: https://doi.org/10.1007/978-3-642-18517-5_19
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62141-3
Online ISBN: 978-3-642-18517-5
eBook Packages: Springer Book Archive